[Infographics] Don’t stop at HF: Screen for ATTR-CM

Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized cause of heart failure (HF), affecting 1 in 10 patients with preserved left ventricular ejection fraction. Read this infographic to learn how to screen for ATTR-CM in HF patients and understand the survival benefits of early tafamidis treatment.

[Edited by Tana]